Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Cash flows from operating activities    
Net loss $ (122,561) $ (239,663)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,039 3,172
Amortization of deferred contract acquisition costs 10,822 4,920
Net amortization of premium on marketable securities 473 558
Stock-based compensation expense 101,454 250,835
Amortization of operating lease right-of-use assets 2,759 1,734
Deferred income taxes 1,594 21
Other non-cash charges (credits), net [1] 2,849 (643)
Changes in operating assets and liabilities:    
Accounts receivable 76,864 35,973
Contract assets (18,523) (8,148)
Deferred contract acquisition costs (20,761) (20,205)
Prepaid expenses and other assets (5,231) 7,666
Accounts payable 7,554 (528)
Accrued expense and other liabilities (12,894) 4,573
Accrued compensation and employee benefits (65,083) (60,433)
Operating lease liabilities, net (1,950) (1,807)
Deferred revenue (14,289) 4,453
Net cash used in operating activities (52,884) (17,522)
Cash flows from investing activities    
Purchases of marketable securities (21,918) (94,157)
Sales of marketable securities 0 89,383
Maturities of marketable securities 14,813 23,755
Purchases of property and equipment (9,692) (2,200)
Capitalization of software development costs 0 (410)
Payment related to business acquisition, net of cash acquired 0 (5,498)
Other investing 1,100 0
Net cash (used in) provided by investing activities (15,697) 10,873
Cash flows from financing activities    
Proceeds from initial public offering, net of underwriting discounts and commissions 0 692,369
Payments of initial public offering costs 0 (2,406)
Proceeds from issuance of convertible preferred stock 0 750,000
Payments of issuance costs for convertible preferred stock 0 (164)
Proceeds from exercise of stock options 2,823 3,114
Payments of tax withholdings on net settlement of equity awards (17,329) 0
Net payments of tax withholdings on sell-to-cover equity award transactions (10,037) 0
Proceeds from employee stock purchase plan contributions 6,356 0
Net cash (used in) provided by financing activities (18,187) 1,442,913
Effect of exchange rate changes (2,738) 2,313
Net (decrease) increase in cash, cash equivalents and restricted cash (89,506) 1,438,577
Cash, cash equivalents, and restricted cash - beginning of period 1,768,723 371,190
Cash, cash equivalents, and restricted cash - end of period 1,679,217 1,809,767
Supplemental disclosure of cash flow information    
Cash paid for interest 277 214
Cash paid for income taxes 2,782 3,076
Supplemental disclosure of non-cash investing and financing activities    
Stock-based compensation capitalized for software development 0 2,151
Value of shares issued in payment of business acquisition 0 30,446
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options 1,355 1,646
Property and equipment included in accounts payable 779 0
Deferred offering costs, accrued but not yet paid 0 1,328
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid $ 7,599 $ 9,218
[1] (1) Prior period amounts have been combined to conform to current presentation